secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aclaris Therapeutics, Inc. (ACRS)
CIK:        0001557746
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001104659-26-002694
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aclaris Therapeutics files 8-K furnishing updated corporate overview; no new financial data disclosed
--------------------------------------------------------------------------------

- Filed Form 8-K on Jan. 12, 2026, updating its corporate overview presentation (Exhibit 99.1).
- Presentation available on company website; no specific financial or operational changes provided in filing.
- No earnings, guidance, clinical results, or other material events disclosed in the filing or exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1557746/000110465926002694/0001104659-26-002694-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1557746/000110465926002694/acrs-20260112x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-002694

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer